×
返回 Agenda
Session 2 : Operation Issues, Protocol Issues
Session Chair(s)
Morihiko Hayashi, DVM
Clinical Development, Clinical Science & Strategy
Chugai Pharmaceutical Co., Ltd., Japan
Speaker(s)
Rare Cancer Treatment Development Platform : MASTER KEY Project
Hitomi Okuma, MD, PhD
National Cancer Center Hospital, Japan
Head, International Research and Development Section
Considerations and Barriers for Clinical Operations in the Basket Study of Entrectinib
Misato Doniwa
IQVIA Services Japan K.K., Japan
Clinical Project Manager, Clinical Operation